Ketazocine (original) (raw)
Ketazocine (INN), also known as ketocyclazocine, is a benzomorphan derivative used in opioid receptor research. Ketazocine, for which the receptor is named, is an exogenous opioid that binds to the κ opioid receptor. Unlike other opioids, substances that only bind to the κ receptor theoretically do not depress the respiratory system. The crystal structure of ketazocine was determined in 1983.
Property | Value |
---|---|
dbo:abstract | Ketazocine (INN), also known as ketocyclazocine, is a benzomorphan derivative used in opioid receptor research. Ketazocine, for which the receptor is named, is an exogenous opioid that binds to the κ opioid receptor. Activation of this receptor is known to cause sleepiness, a decrease in pain sensation and (potentially) dysphoria, paranoia, and hallucinations. It also causes an increase in urine production because it inhibits the release of vasopressin. (Vasopressin is an endogenous substance that assists in regulating fluid and electrolyte balance in the body and decreases the amount of water released into the urine.) Unlike other opioids, substances that only bind to the κ receptor theoretically do not depress the respiratory system. The crystal structure of ketazocine was determined in 1983. (en) La chetazocina (INN), anche nota come chetociclazocina, è un derivato del benzomorfano utilizzato nella ricerca sui recettori oppioidi. La chetociclazocina è un oppioide esogeno che lega i recettori κ-oppioidi. L'attivazione di questo recettore è noto per causare sonnolenza, una riduzione della percezione del dolore e (potenzialmente) anche disforia, paranoia e allucinazioni. È anche causa di un aumento nella produzione urinaria in quanto inibisce il rilascio di vasopressina (è una sostanza endogena che coadiuva la regolazione del bilanciamento elettrolitico e dei fluidi nel corpo umano modulando la quantità di acqua rilasciata con le urine). (it) |
dbo:casNumber | 36292-69-0 |
dbo:fdaUniiCode | 6IO4IG518S |
dbo:kegg | D04649 |
dbo:pubchem | 3054741 |
dbo:thumbnail | wiki-commons:Special:FilePath/Ketazocine_structure.svg?width=300 |
dbo:wikiPageID | 10059251 (xsd:integer) |
dbo:wikiPageLength | 3091 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID | 1113856705 (xsd:integer) |
dbo:wikiPageWikiLink | dbr:Benzomorphan dbr:Respiratory_system dbr:Vasopressin dbc:Ketones dbc:Phenols dbr:Opioid_receptor dbc:Kappa-opioid_receptor_agonists dbc:Benzomorphans dbr:Dysphoria dbr:Paranoia dbr:Endogenous dbc:Synthetic_opioids dbr:Hallucinations dbr:International_Nonproprietary_Name dbr:Exogenous dbr:Ethylketazocine dbr:Κ_opioid_receptor |
dbp:atcPrefix | none (en) |
dbp:c | 18 (xsd:integer) |
dbp:casNumber | 36292 (xsd:integer) |
dbp:chemspiderid | 2316328 (xsd:integer) |
dbp:h | 23 (xsd:integer) |
dbp:iupacName | -3 (xsd:integer) |
dbp:kegg | D04649 (en) |
dbp:n | 1 (xsd:integer) |
dbp:o | 2 (xsd:integer) |
dbp:pubchem | 3054741 (xsd:integer) |
dbp:routesOfAdministration | Oral (en) |
dbp:smiles | O=C2c1c[C@]3C (en) |
dbp:stdinchi | 1 (xsd:integer) |
dbp:stdinchikey | HQBZLVPZOGIAIQ-SDDDUWNISA-N (en) |
dbp:unii | 6 (xsd:integer) |
dbp:verifiedrevid | 443949789 (xsd:integer) |
dbp:wikiPageUsesTemplate | dbt:Drugbox dbt:Hallucinogens dbt:Opioidergics dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite |
dcterms:subject | dbc:Ketones dbc:Phenols dbc:Kappa-opioid_receptor_agonists dbc:Benzomorphans dbc:Synthetic_opioids |
rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Abstraction100002137 yago:Chemical114806838 yago:Compound114818238 yago:Ketone114926294 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:Phenol114989545 yago:PhysicalEntity100001930 yago:Relation100031921 yago:WikicatKetones dbo:Drug yago:Substance100019613 yago:WikicatPhenols umbel-rc:ChemicalSubstanceType |
rdfs:comment | Ketazocine (INN), also known as ketocyclazocine, is a benzomorphan derivative used in opioid receptor research. Ketazocine, for which the receptor is named, is an exogenous opioid that binds to the κ opioid receptor. Unlike other opioids, substances that only bind to the κ receptor theoretically do not depress the respiratory system. The crystal structure of ketazocine was determined in 1983. (en) La chetazocina (INN), anche nota come chetociclazocina, è un derivato del benzomorfano utilizzato nella ricerca sui recettori oppioidi. La chetociclazocina è un oppioide esogeno che lega i recettori κ-oppioidi. (it) |
rdfs:label | Ketazocine (en) Chetazocina (it) |
owl:sameAs | freebase:Ketazocine yago-res:Ketazocine wikidata:Ketazocine dbpedia-it:Ketazocine dbpedia-sh:Ketazocine dbpedia-sr:Ketazocine https://global.dbpedia.org/id/4pXJo |
prov:wasDerivedFrom | wikipedia-en:Ketazocine?oldid=1113856705&ns=0 |
foaf:depiction | wiki-commons:Special:FilePath/Ketazocine_structure.svg |
foaf:isPrimaryTopicOf | wikipedia-en:Ketazocine |
is dbo:wikiPageRedirects of | dbr:Ketocyclazocine |
is dbo:wikiPageWikiLink of | dbr:Benzomorphan dbr:List_of_opioids dbr:C18H23NO2 dbr:Psychotomimetism dbr:Spiradoline dbr:Opioid dbr:Ethylketazocine dbr:Κ-opioid_receptor dbr:Sigma-1_receptor dbr:List_of_drugs:_K dbr:Volazocine dbr:Ketocyclazocine |
is foaf:primaryTopic of | wikipedia-en:Ketazocine |